Search – Page 136 – Indianapolis Business Journal

Home » Search

Articles

RCA firm grows with LED popularity

October 27, 2016

For decades, the RCA brand has been associated with televisions and other consumer electronics. But it’s LED lighting that’s helping fuel growth for Indianapolis-based RCA Commercial Electronics.

LOU’S VIEWS: Hardwood hindsight and hopes on display at Historical Society

October 28, 2016

In pursuit of the essence of Hoosier basketball, photographers Michael E. Keating and Chris Smith logged over 10,000 miles and visited 130 gyms across the state, taking more than 150,000 photos along the way.

2016 WOMAN OF INFLUENCE: Amy Judge-Prein

October 28, 2016

A champion for alternative scheduling to attract, retain and develop workers, Amy Judge-Prein focuses on regulatory and strategic aspects of the development of pharmaceuticals, medical devices and diagnostics.

Lilly shares slip after Bernie Sanders criticizes insulin prices

November 2, 2016

Makers of insulin became the latest target for Sen. Bernie Sanders, who has been going after pharmaceutical companies one by one over the issue of high U.S. drug prices.

Writing about my own cancer

November 3, 2016

Writing about medical research is one thing. Learning about your own cancer—then trying to write about it—is another.

New pricing pressure hinders Lilly push to kick-start sales

November 3, 2016

The company's top-selling product, the insulin Humalog, saw U.S. sales by volume rise 10 percent in the third quarter. But because of rebates and other discounts, revenue dropped 14 percent.

Drugmakers’ stocks jump on promise of Trump presidency

November 9, 2016

Pharmaceutical company stocks were among the winners in early trading Wednesday as Republicans’ sweeping election victory eased concerns that Democrats would enact controls on drug prices. Eli Lilly and Co. shares jumped 4 percent.

Electric cars slow to catch on among Hoosiers

November 9, 2016

Through August, only about 1.7 percent of the 170,000 new cars registered in Indiana this year were gas-electric hybrids.

Records for Nov. 14-20, 2016

November 9, 2016

Here are the records listings for Nov. 14-20. 2016.

From banker to caregiver, Steve Schenck has memories to cherish

November 17, 2016

Schenck's wife, Becky, was diagnosed with terminal brain cancer in 2006 and told she had only 12 to 15 months to live. She defied the odds and lived 10 years beyond her prognosis—time together Steve cherishes and wouldn’t trade for anything.

Lilly CEO: Find overlap between corporate mission, philanthropy

November 18, 2016

John Lechleiter told local leaders Friday morning that while community engagement might not immediately impact the bottom line, it can be beneficial to a company’s ongoing mission.

Lilly’s Alzheimer’s disease drug fails in final-stage trial

November 23, 2016

The Indianapolis drugmaker’s shares tumbled 14 percent in premarket trading after the company announced solanezumab failed to slow the progression of the neurodegenerative disease.

Failure of Lilly’s Alzheimer’s drug not a big surprise to analysts

November 23, 2016

Investors pummeled Eli Lilly and Co.’s stock Wednesday on the news that its experimental drug for Alzheimer’s disease failed to help patients, but a chorus of pharmaceutical analysts say they weren’t shocked by the setback.

Expanding pre-K takes more than money

November 23, 2016

Early education advocates want lawmakers to expand funding for pre-K programs but challenges to expansion also include creating or expanding existing highly rated child care programs and recruiting and retaining a well-trained preschool workforce.

Holcomb to lead Indiana delegation to United Kingdom

November 28, 2016

During the trip, Holcomb will meet with government officials in London as well as potential investors in Indiana's top business sectors, including advanced manufacturing.

Buy, sell or hold after Lilly’s Alzheimer’s flop?

November 28, 2016

Analysts are all over the map on how investors should react to the Indianapolis-based drugmaker’s news that a promising drug failed to help patients.

‘Flexible’ lease space for tech firms to open downtown next year

November 30, 2016

A group of real estate investors have made a $10 million bet that they can sell leases in with terms as short as one year to adolescent tech companies.

At Eli Lilly, tears, heartbreak and renewed determination

December 1, 2016

Eli Lilly and Co. employees knew the Alzheimer's treatment solanezumab was not a sure bet. But that didn’t make the pain any less acute after the company announced the drug had failed to demonstrate effectiveness during a 2,100-patient Phase 3 clinical trial.

Lilly to lay off hundreds after failure of Alzheimer’s drug

December 2, 2016

Eli Lilly and Co. plans to lay off hundreds of U.S. sales representatives in coming months, following the disappointing failure of an experimental drug for Alzheimer’s disease announced last week.

Lilly competitor to cap price increases as drug costs face more scrutiny

December 5, 2016

With drug companies under fire, the world’s largest insulin maker plans to limit price increases and introducing a model that ties the cost of medicines to the results they deliver.

« Previous 1 … 134 135 136 137 138 … 221 Next »

Search Results

4,411 results for '\"eli lilly\"'

Articles

RCA firm grows with LED popularity

LOU’S VIEWS: Hardwood hindsight and hopes on display at Historical Society

2016 WOMAN OF INFLUENCE: Amy Judge-Prein

Lilly shares slip after Bernie Sanders criticizes insulin prices

Writing about my own cancer

New pricing pressure hinders Lilly push to kick-start sales

Drugmakers’ stocks jump on promise of Trump presidency

Electric cars slow to catch on among Hoosiers

Records for Nov. 14-20, 2016

From banker to caregiver, Steve Schenck has memories to cherish

Lilly CEO: Find overlap between corporate mission, philanthropy

Lilly’s Alzheimer’s disease drug fails in final-stage trial

Failure of Lilly’s Alzheimer’s drug not a big surprise to analysts

Expanding pre-K takes more than money

Holcomb to lead Indiana delegation to United Kingdom

Buy, sell or hold after Lilly’s Alzheimer’s flop?

‘Flexible’ lease space for tech firms to open downtown next year

At Eli Lilly, tears, heartbreak and renewed determination

Lilly to lay off hundreds after failure of Alzheimer’s drug

Lilly competitor to cap price increases as drug costs face more scrutiny